Literature DB >> 10925290

The MHC class II molecule I-Ag7 exists in alternate conformations that are peptide dependent.

L S Arneson1, M Peterson, A J Sant.   

Abstract

Insulin-dependent diabetes mellitus is an autoimmune disease that is genetically linked to the HLA class II molecule DQ in humans and to MHC I-Ag7 in nonobese diabetic mice. The I-Ag7 beta-chain is unique and contains multiple polymorphisms, at least one of which is shared with DQ alleles linked to insulin-dependent diabetes mellitus. This polymorphism occurs at position 57 in the beta-chain, in which aspartic acid is mutated to a serine, a change that results in the loss of an interchain salt bridge between alphaArg76 and betaAsp57 at the periphery of the peptide binding groove. Using mAbs we have identified alternative conformations of I-Ag7 class II molecules. By using an invariant chain construct with various peptides engineered into the class II-associated invariant chain peptide (CLIP) region we have found that formation of these conformations is dependent on the peptide occupying the binding groove. Blocking studies with these Abs indicate that these conformations are present at the cell surface and are capable of interactions with TCRs that result in T cell activation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10925290     DOI: 10.4049/jimmunol.165.4.2059

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  2 in total

Review 1.  On the perils of poor editing: regulation of peptide loading by HLA-DQ and H2-A molecules associated with celiac disease and type 1 diabetes.

Authors:  Robert Busch; Alessandra De Riva; Andreas V Hadjinicolaou; Wei Jiang; Tieying Hou; Elizabeth D Mellins
Journal:  Expert Rev Mol Med       Date:  2012-07-06       Impact factor: 5.600

2.  Glutamic acid decarboxylase-derived epitopes with specific domains expand CD4(+)CD25(+) regulatory T cells.

Authors:  Guojiang Chen; Gencheng Han; Jiannan Feng; Jianan Wang; Renxi Wang; Ruonan Xu; Beifen Shen; Jiahua Qian; Yan Li
Journal:  PLoS One       Date:  2009-09-13       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.